Carboplatin/Pemetrexed clinical trials

Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)

This study is looking at giving a new treatment called amivantamab, sometimes with chemotherapy, before surgery for a certain type of lung cancer. It aims to see if this approach is practical and helpful for patients with specific gene changes in their cancer.